Showing results (131-140 of 1,026) with videos related to
Sort By:
Pageof 103
Current Treatment Options in Oncology|August 3, 2013
Anaplastic oligodendroglioma: a new treatment paradigm and current controversiesPatrick Roth, Wolfgang Wick, Michael WellerNeuro-Oncology Practice|June 3, 2015
Corticosteroid use in neuro-oncology: an updatePatrick Roth, Caroline Happold, Michael WellerOncology Research and Treatment|June 5, 2016
Immunotherapy of Brain CancerPatrick Roth, Matthias Preusser, Michael WellerCurrent Neurology and Neuroscience Reports|March 22, 2017
Management of Elderly Patients with GlioblastomaPatrick Roth, Dorothee Gramatzki, Michael WellerCurrent Pharmaceutical Design|February 4, 2006
Transforming growth factor-beta: a molecular target for the future therapy of glioblastomaWolfgang Wick, Ulrike Naumann, Michael WellerHuman Immunology|November 7, 2003
Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathiesHeinz Wiendl, Meike Mitsdoerffer, Michael WellerBiochemical Pharmacology|December 27, 2016
The network of immunosuppressive pathways in glioblastomaDavide Mangani, Michael Weller, Patrick RothGlia|May 6, 2003
Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexinsJohannes Rieger, Wolfgang Wick, Michael WellerExpert Review of Anticancer Therapy|September 7, 2016
Immunological effects of chemotherapy and radiotherapy against brain tumorsTobias Weiss, Michael Weller, Patrick RothJournal of Immunology (Baltimore, Md. : 1950)|May 10, 2017
Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-β and Furin in Glioma-Initiating CellsElisa Ventura, Michael Weller, Isabel BurghardtPageof 103